Dias Murilo Bacchini, Avelino-Silva Thiago J, Ferriolli Eduardo, Taniguchi Leandro Utino, Jacob-Filho Wilson, Suemoto Claudia Kimie, Aliberti Márlon Juliano Romero
Laboratorio de Investigação Medica em Envelhecimento (LIM-66), Serviço de Geriatria, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil.
Division of Geriatrics, University of California, San Francisco, California, USA.
J Am Geriatr Soc. 2025 Jun;73(6):1722-1732. doi: 10.1111/jgs.19490. Epub 2025 May 8.
Hospitalization frequently results in persistent symptoms among older adults, raising concerns about the long-term impacts of acute events-a problem amplified by COVID-19. We investigated the effects of persistent symptoms on functional decline and unplanned events over 1 year in older patients recovering from COVID-19 hospitalization.
This prospective cohort included patients aged ≥ 50 years who survived COVID-19 hospitalization between March and December 2020 as part of the CO-FRAIL study at Brazil's largest academic medical center. Persistent symptoms were defined as those reported at admission and continuously present at one-, three-, six-, nine-, and 12-month post-discharge, covering 16 symptoms. Outcomes included functional decline in basic activities of daily living (ADL), mobility activities, instrumental activities of daily living (IADL), number of falls, emergency department (ED) visits, and hospital readmissions. Associations between persistent symptoms and outcomes were examined using mixed-effects negative binomial regression models adjusted for sociodemographic, clinical, hospitalization-related factors, and post-discharge rehabilitation.
Among 1019 patients (mean age = 65 ± 10 years; women = 45%; White = 62%), 324 (32%) experienced persistent symptoms throughout the year. Fatigue (28%), myalgia (19%), and dyspnea (13%) were the most common. Patients with ≥ 2 symptoms had an increased risk of functional decline in mobility activities (IRR = 2.11; 95% CI = 1.50-2.96), IADL (IRR = 2.00; 95% CI = 1.44-2.79), falls (IRR = 2.56; 95% CI = 1.14-5.75), and ED visits (IRR = 2.69; 95% CI = 1.27-5.70), but not readmissions. Among women, ≥ 1 persistent symptom was associated with a twofold increased risk of ADL decline. One year after discharge, patients with ≥ 2 persistent symptoms developed 1.27 more new disabilities (3.26 vs. 1.99 on a 15-point functional scale) and had 31 more unplanned events per 100 person-years (54.3 vs. 23.2) than those without symptoms.
Persistent symptoms after hospitalization are common and contribute to functional decline, falls, and ED visits in older COVID-19 survivors. These findings suggest that greater attention to symptom burden may support risk identification and improve post-discharge care planning.
住院治疗常常会导致老年人出现持续症状,这引发了人们对急性事件长期影响的担忧——而新冠疫情使这一问题更加严重。我们调查了持续症状对新冠病毒感染住院康复的老年患者1年以上功能衰退和意外事件的影响。
这项前瞻性队列研究纳入了年龄≥50岁的患者,这些患者在2020年3月至12月期间从新冠病毒感染住院中康复,是巴西最大的学术医疗中心进行的CO-FRAIL研究的一部分。持续症状定义为入院时报告且在出院后1个月、3个月、6个月、9个月和12个月持续存在的症状,涵盖16种症状。结局包括日常生活基本活动(ADL)功能衰退、移动活动、日常生活工具性活动(IADL)、跌倒次数、急诊就诊次数和再次入院情况。使用混合效应负二项回归模型检验持续症状与结局之间的关联,并对社会人口统计学、临床、住院相关因素和出院后康复情况进行了调整。
在1019名患者中(平均年龄=65±10岁;女性=45%;白人=62%),324名(32%)患者全年都有持续症状。疲劳(28%)、肌痛(19%)和呼吸困难(13%)是最常见的症状。有≥2种症状的患者在移动活动(IRR=2.11;95%CI=1.50-2.96)、IADL(IRR=2.00;95%CI=1.44-2.79)、跌倒(IRR=2.56;95%CI=1.14-5.75)和急诊就诊(IRR=2.69;95%CI=1.27-5.70)方面功能衰退的风险增加,但再次入院情况并非如此。在女性中,≥1种持续症状与ADL衰退风险增加两倍相关。出院1年后,有≥2种持续症状的患者比无症状患者多出现1.27种新的残疾(在15分功能量表上为3.26分对1.99分),每100人年多发生31次意外事件(54.3次对23.2次)。
住院后的持续症状很常见,会导致新冠病毒感染老年幸存者出现功能衰退、跌倒和急诊就诊。这些发现表明,更多地关注症状负担可能有助于识别风险并改善出院后护理计划。